Related Experiment Video
Updated: Nov 15, 2025

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
Chronic tissue inflammation and metabolic disease
Yun Sok Lee1, Jerrold Olefsky1
1Department of Medicine, Division of Endocrinology and Metabolism, University of California at San Diego, La Jolla, California 92093, USA.
Obesity causes insulin resistance and type 2 diabetes (T2DM) through chronic inflammation. Understanding immunometabolism offers new therapeutic targets for metabolic dysfunction.
Area of Science:
- Immunometabolism
- Obesity research
- Inflammation biology
Background:
- Obesity is a primary driver of insulin resistance and type 2 diabetes (T2DM).
- Chronic, low-grade tissue inflammation is a key factor in obesity-related metabolic dysfunction.
- The interplay between immune responses and metabolic processes (immunometabolism) is crucial.
Purpose of the Study:
- To summarize recent advancements in understanding immunometabolism.
- To elucidate the mechanisms of chronic inflammation in metabolic tissues during obesity.
- To review current and novel immunomodulatory therapeutic strategies.
Main Methods:
- Review of recent scientific literature on immunometabolism and obesity.
- Analysis of inflammatory pathways in key metabolic tissues.
- Discussion of obesity-induced triggers like adipose tissue hypoxia and macrophage exosomes.
Main Results:
- Obesity triggers chronic inflammation in metabolic tissues.
- Adipose tissue hypoxia and macrophage-derived exosomes play significant roles.
- Current immunomodulatory therapies show promise.
Conclusions:
- Targeting immunometabolism is a promising approach for treating obesity-related insulin resistance and T2DM.
- Further research into inflammation mechanisms and exosome function is warranted.
- Immunomodulation offers potential for novel therapeutic interventions.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammation
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

